Patent US5892020A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5892020A Expired / Lapsed US ⏱️ 0.0 years remaining

Multivalent single chain antibodies

Assignee: United States Department of Health and Human Services
•
Filing: 1995-06-07
•
Granted: 1999-04-06
•
Expires: 2015-06-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention discloses multivalent single chain antibodies which have two or more biologically active antigen binding sites. The multivalent single chain antibodies are formed by using a peptide linker to covalently link two or more single chain antibodies, each single chain antibody having a variable light domain linked to a variable heavy chain domain by a peptide linker.

Inventors

  • 👤 Peter S. Mezes
  • 👤 Brian B. Gourlie

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 22:53
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; C07K16/28; C07K16/30; C07K16/42; C07K16/4208; C07K16/4241; C07K16/4258; C07K16/4266; A; A61; A61K; A61K38/00; C07K2317/00; C07K2317/60; C07K2317/62; C07K2317/622; C07K2319/00

Claims Analysis

Total Claims: 25
Claim 1
Independent Claim 247 words
A DNA sequence which codes for a multivalent single chain antibody, the multivalent single chain antibody comprising two or more single chain antibodies and at least one first peptide linker, each single chain antibody having affinity for TAG-72, each single chain antibody being covalently linked by at least one of said first peptide linkers to at least one other single chain antibody and each single chain antibody comprising: (a) a first polypeptide comprising a light chain variable domain encoded by a base sequence whose expression product is substantially homologous to that having the amino acid sequence (SEQ ID NO: 2) of ______________________________________ AspIleValMetSerGlnSerProSerSerLeuPro ValSerValGlyGluLysValThrLeuSerCysLys SerSerGlnSerLeuLeuTyrSerGlyAsnGlnLys AsnTyrLeuAlaTrpTyrGlnGlnLysProGlyGln SerProLysLeuLeuIleTyrTrpAlaSerAlaArg GluSerGlyValProAspArgPheThrGlySerGly SerGlyThrAspPheThrLeuSerIleSerSerVal LysThrGluAspLeuAlaValTyrTyrCysGlnGln TyrTyrSerTyrProLeuThrPheGlyAlaGlyThr LysLeuValLeuLys ______________________________________ and whose expression product retains the characteristic of functional binding to TAG-72; (b) a second polypeptide comprising a heavy chain variable domain encoded by a base sequence whose expression product is substantially homologous to that having the amino acid sequence (SEQ ID NO: 4) of ______________________________________ GluValGlnLeuGlnGlnSerAspAlaGluLeuVal LysProGlyAlaSerValLysIleSerCysLysAla SerGlyTyrThrPheThrAspHisAlaIleHisTrp ValLysGlnAsnProGluGlnGlyLeuGluTrpIle GlyTyrPheSerProGlyAsnAspAspPheLysTyr AsnGluArgPheLysGlyLysAlaThrLeuThrAla AspLysSerSerSerThrAlaTyrValGlnLeuAsn SerLeuThrSerGluAspSerAlaValTyrPheCys ThrArgSerLeuAsnMetAlaTyrTrpGlyGlnGly ThrSerValThrValSerSer ______________________________________ and whose expression product retains the characteristic of functional binding to TAG-72; and (c) a second peptide linker linking the first and second polypeptides into a functional binding moiety; wherein said first peptide linker comprises a 15-25 amino acid segment of the amino acid sequence (SEQ ID NO: 5), Leu-Ser-Ala-Asp-Asp-Ala-Lys-Lys-Asp-Ala-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Leu, and said multivalent single chain antibody has an affinity of at least 60% of that of a native anti-TAG-72 antibody, as measured by a competitive binding assay.
Claim 2
Dependent Claim 247 words
A DNA sequence which codes for a multivalent single chain antibody, the multivalent single chain antibody comprising two or more single chain antibodies and at least one first peptide linker, each single chain antibody having affinity for TAG-72, each single chain antibody being covalently linked by at least one of said first peptide linkers to at least one other single chain antibody and each single chain antibody comprising: (a) a first polypeptide comprising a light chain variable domain encoded by a base sequence whose expression product is substantially homologous to that having the amino acid sequence (SEQ ID NO: 2) of ______________________________________ AspIleValMetSerGlnSerProSerSerLeuPro ValSerValGlyGluLysValThrLeuSerCysLys SerSerGlnSerLeuLeuTyrSerGlyAsnGlnLys AsnTyrLeuAlaTrpTyrGlnGlnLysProGlyGln SerProLysLeuLeuIleTyrTrpAlaSerAlaArg GluSerGlyValProAspArgPheThrGlySerGly SerGlyThrAspPheThrLeuSerIleSerSerVal LysThrGluAspLeuAlaValTyrTyrCysGlnGln TyrTyrSerTyrProLeuThrPheGlyAlaGlyThr LysLeuValLeuLys ______________________________________ and whose expression product retains the characteristic of functional binding to TAG-72; (b) a second polypeptide comprising a heavy chain variable domain encoded by a base sequence whose expression product is substantially homologous to that having the amino acid sequence (SEQ ID NO: 4) of ______________________________________ GluValGlnLeuGlnGlnSerAspAlaGluLeuVal LysProGlyAlaSerValLysIleSerCysLysAla SerGlyTyrThrPheThrAspHisAlaIleHisTrp ValLysGlnAsnProGluGlnGlyLeuGluTrpIle GlyTyrPheSerProGlyAsnAspAspPheLysTyr AsnGluArgPheLysGlyLysAlaThrLeuThrAla AspLysSerSerSerThrAlaTyrValGlnLeuAsn SerLeuThrSerGluAspSerAlaValTyrPheCys ThrArgSerLeuAsnMetAlaTyrTrpGlyGlnGly ThrSerValThrValSerSer ______________________________________ and whose expression product retains the characteristic of functional binding to TAG-72; and (c) a second peptide linker linking the first and second polypeptides into a functional binding moiety; wherein said first peptide linker comprises a 15-25 amino acid segment of the amino acid sequence (SEQ ID NO: 5), Leu-Ser-Ala-Asp-Asp-Ala-Lys-Lys-Asp-Ala-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Leu, and said multivalent single chain antibody has an affinity of at least 60% of that of a native anti-TAG-72 antibody, as measured by a competitive binding assay.
Claim 3
Dependent Claim 135 words
A DNA sequence which codes for a multivalent single chain antibody, the multivalent single chain antibody comprising two or more single chain antibodies and at least one first peptide linker, each single chain antibody (a) having affinity for TAG-72; (b) being covalently linked, by at least one of said first peptide linkers, to at least one other single chain antibody; and (c) comprising a first polypeptide capable of binding TAG-72, covalently linked by a second peptide linker to a second polypeptide capable of binding TAG-72; wherein: (1) the first peptide linker comprises a 15-25 amino acid segment of the amino acid sequence (SEQ ID NO: 5), Leu-Ser-Ala-Asp-Asp-Ala-Lys-Lys-Asp-Ala-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Leu; and (2) the multivalent single chain antibody has an affinity of at least 60% of that of a native anti-TAG-72 antibody, as measured by a competitive binding assay.
Claim 4
Dependent Claim 135 words
A DNA sequence which codes for a multivalent single chain antibody, the multivalent single chain antibody comprising two or more single chain antibodies and at least one first peptide linker, each single chain antibody (a) having affinity for TAG-72; (b) being covalently linked, by at least one of said first peptide linkers, to at least one other single chain antibody; and (c) comprising a first polypeptide capable of binding TAG-72, covalently linked by a second peptide linker to a second polypeptide capable of binding TAG-72; wherein: (1) the first peptide linker comprises a 15-25 amino acid segment of the amino acid sequence (SEQ ID NO: 5), Leu-Ser-Ala-Asp-Asp-Ala-Lys-Lys-Asp-Ala-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Leu; and (2) the multivalent single chain antibody has an affinity of at least 60% of that of a native anti-TAG-72 antibody, as measured by a competitive binding assay.
Claim 5
Dependent Claim 80 words
The DNA sequence of claim 2 wherein the sequence coding for the first polypeptide comprises a base sequence whose expression product has the amino acid sequence (SEQ ID NO: 2) of ______________________________________ AspIleValMetSerGlnSerProSerSerLeuPro ValSerValGlyGluLysValThrLeuSerCysLys SerSerGlnSerLeuLeuTyrSerGlyAsnGlnLys AsnTyrLeuAlaTrpTyrGlnGlnLysProGlyGln SerProLysLeuLeuIleTyrTrpAlaSerAlaArg GluSerGlyValProAspArgPheThrGlySerGly SerGlyThrAspPheThrLeuSerIleSerSerVal LysThrGluAspLeuAlaValTyrTyrCysGlnGln TyrTyrSerTyrProLeuThrPheGlyAlaGlyThr LysLeuValLeuLys ______________________________________ and the sequence coding for the second polypeptide comprises a base sequence whose expression product has the amino acid sequence (SEQ ID NO: 4) of ______________________________________ GluValGlnLeuGlnGlnSerAspAlaGluLeuVal LysProGlyAlaSerValLysIleSerCysLysAla SerGlyTyrThrPheThrAspHisAlaIleHisTrp ValLysGlnAsnProGluGlnGlyLeuGluTrpIle GlyTyrPheSerProGlyAsnAspAspPheLysTyr AsnGluArgPheLysGlyLysAlaThrLeuThrAla AspLysSerSerSerThrAlaTyrValGlnLeuAsn SerLeuThrSerGluAspSerAlaValTyrPheCys ThrArgSerLeuAsnMetAlaTyrTrpGlyGlnGly ThrSerValThrValSerSer. ______________________________________
Claim 6
Dependent Claim 272 words
The DNA sequence of claim 3 wherein the sequence coding for the first polypeptide comprises a base sequence (SEQ ID NO: 1) of ______________________________________ GAC ATT GTG ATG TCA CAG TCT CCA TCC TCC CTA CCT GTG TCA GTT GGC GAG AAG GTT ACT TTG AGC TGC AAG TCC AGT CAG AGC CTT TTA TAT AGT GGT AAT CAA AAG AAC TAC TTG GCC TGG TAC CAG CAG AAA CCA GGG CAG TCT CCT AAA CTG CTG ATT TAC TGG GCA TCC GCT AGG GAA TCT GGG GTC CCT GAT CGC TTC ACA GGC AGT GGA TCT GGG ACA GAT TTC ACT CTC TCC ATC AGC AGT GTG AAG ACT GAA GAC CTG GCA GTT TAT TAC TGT CAG CAG TAT TAT AGC TAT CCC CTC ACG TTC GGT GCT GGG ACC AAG CTG GTG CTG AAG ______________________________________ and the sequence coding for the second polypeptide comprises a base sequence (SEQ ID NO: 3) of ______________________________________ GAG GTT CAG TTG CAG CAG TCT GAC GCT GAG TTG GTG AAA CCT GGG GCT TCA GTG AAG ATT TCC TGC AAG GCT TCT GGC TAC ACC TTC ACT GAC CAT GCA ATT CAC TGG GTG AAA CAG AAC CCT GAA CAG GGC CTG GAA TGG ATT GGA TAT TTT TCT CCC GGA AAT GAT GAT TTT AAA TAC AAT GAG AGG TTC AAG GGC AAG GCC ACA CTG ACT GCA GAC AAA TCC TCC AGC ACT GCC TAC GTG CAG CTC AAC AGC CTG ACA TCT GAG GAT TCT GCA GTG TAT TTC TGT ACA AGA TCC CTG AAT ATG GCC TAC TGG GGT CAA GGA ACC TCA GTC ACC GTC TCC TCA. ______________________________________
Claim 7
Dependent Claim 29 words
The DNA sequence of claim 2 wherein said multivalent single chain antibody comprises only two of said single chain antibodies covalently linked together by one said first peptide linker.
Claim 8
Dependent Claim 14 words
The DNA sequence of claim 2 wherein said DNA sequence is a contiguous sequence.
Claim 9
Dependent Claim 15 words
The DNA sequence of claim 2 wherein said DNA sequence comprises at least two exons.
Claim 10
Dependent Claim 29 words
The DNA sequence of claim 4 wherein said multivalent single chain antibody comprises only two of said single chain antibodies covalently linked together by one said first peptide linker.
Claim 11
Dependent Claim 23 words
The DNA sequence of claim 3 wherein said first and second peptide linkers are about 10 to about 50 amino acids in length.
Claim 12
Dependent Claim 19 words
The DNA sequence of claim 9 wherein said linkers are about 12 to about 30 amino acids in length.
Claim 13
Dependent Claim 16 words
The DNA sequence of claim 10 wherein said linkers are about 25 amino acids in length.
Claim 14
Dependent Claim 21 words
The DNA sequence of claim 11 wherein said linkers comprise the 25 amino acid sequence (SEQ ID NO: 5) of Leu-Ser-Ala-Asp-Asp-Ala-Lys-Lys-Asp-Ala-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Leu.
Claim 15
Dependent Claim 14 words
The DNA sequence of claim 4 wherein said DNA sequence is a contiguous sequence.
Claim 16
Dependent Claim 15 words
The DNA sequence of claim 4 wherein said DNA sequence comprises at least two exons.
Claim 17
Dependent Claim 27 words
The DNA sequence of claim 2 wherein said second peptide linker comprises a 15-25 amino acid segment of the amino acid sequence (SEQ ID NO: 5), Leu-Ser-Ala-Asp-Asp-Ala-Lys-Lys-Asp-Ala-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Leu.
Claim 18
Dependent Claim 23 words
The DNA sequence of claim 2 wherein said first and second peptide linkers are about 10 to about 50 amino acids in length.
Claim 19
Dependent Claim 19 words
The DNA sequence of claim 16 wherein said linkers are about 12 to about 30 amino acids in length.
Claim 20
Dependent Claim 16 words
The DNA sequence of claim 17 wherein said linkers are about 25 amino acids in length.
Claim 21
Dependent Claim 21 words
The DNA sequence of claim 18 wherein said linkers consist of the 25 amino acid sequence (SEQ ID NO: 5), Leu-Ser-Ala-Asp-Asp-Ala-Lys-Lys-Asp-Ala-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Asp-Ala-Lys-Lys-Asp-Leu.
Claim 22
Dependent Claim 288 words
The DNA sequence of claim 1 wherein the sequence coding for the first polypeptide comprises a base sequence whose expression product has the amino acid sequence (SEQ ID NO: 2) of ______________________________________ Asp Ile Val Met Ser Gln Ser Pro Ser Ser Leu Pro Val Ser Val Gly Glu Lys Val Thr Leu Ser Cys Lys Ser Ser Gln Ser Leu Leu Tyr Ser Gly Asn Gln Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Lys Leu Leu Ile Tyr Trp Ala Ser Ala Arg Glu Ser Gly Val Pro Asp Arg Phe Thr Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Ser Ser Val Lys Thr Glu Asp Leu Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr Ser Tyr Pro Leu Thr Phe Gly Ala Gly Thr Lys Leu Val Leu Lys ______________________________________ and the sequence coding for the second polypeptide comprises a base sequence whose expression product has the amino acid sequence (SEQ ID NO: 4) of ______________________________________ Glu Val Gln Leu Gln Gln Ser Asp Ala Glu Leu Val Lys Pro Gly Ala Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp His Ala Ile His Tip Val Lys Gln Asn Pro Glu Gln Gly Leu Glu Trp Ile Gly Tyr Phe Ser Pro Gly Asn Asp Asp Phe Lys Tyr Asn Glu Arg Phe Lys Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr Val Gln Leu Asn Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys Thr Arg Ser Leu Asn Met Ala Tyr Trp Gly Gln Gly Thr Ser Val Thr Val Ser ______________________________________ Ser.
Claim 23
Dependent Claim 272 words
The DNA sequence of claim 20 wherein the sequence coding for the first polypeptide comprises a base sequence (SEQ ID NO: 1) of ______________________________________ GAC ATT GTG ATG TCA CAG TCT CCA TCC TCC CTA CCT GTG TCA GTT GGC GAG AAG GTT ACT TTG AGC TGC AAG TCC AGT CAG AGC CTT TTA TAT AGT GGT AAT CAA AAG AAC TAC TTG GCC TGG TAC CAG CAG AAA CCA GGG CAG TCT CCT AAA CTG CTG ATT TAC TGG GCA TCC GCT AGG GAA TCT GGG GTC CCT GAT CGC TTC ACA GGC AGT GGA TCT GGG ACA GAT TTC ACT CTC TCC ATC AGC AGT GTG AAG ACT GAA GAC CTG GCA GTT TAT TAC TGT CAG CAG TAT TAT AGC TAT CCC CTC ACG TTC GGT GCT GGG ACC AAG CTG GTG CTG AAG ______________________________________ and the sequence coding for the second polypeptide comprises a base sequence (SEQ ID NO: 3) of ______________________________________ GAG GTT CAG TTG CAG CAG TCT GAC GCT GAG TTG GTG AAA CCT GGG GCT TCA GTG AAG ATT TCC TGC AAG GCT TCT GGC TAC ACC TTC ACT GAC CAT GCA ATT CAC TGG GTG AAA CAG AAC CCT GAA CAG GGC CTG GAA TGG ATT GGA TAT TTT TCT CCC GGA AAT GAT GAT TTT AAA TAC AAT GAG AGG TTC AAG GGC AAG GCC ACA CTG ACT GCA GAC AAA TCC TCC AGC ACT GCC TAC GTG CAG CTC AAC AGC CTG ACA TCT GAG GAT TCT GCA GTG TAT TTC TGT ACA AGA TCC CTG AAT ATG GCC TAC TGG GGT CAA GGA ACC TCA GTC ACC GTC TCC TCA. ______________________________________
Claim 24
Dependent Claim 23 words
The DNA sequence of claim 1 wherein said first and second peptide linkers are about 10 to about 50 amino acids in length.
Claim 25
Dependent Claim 16 words
The DNA sequence of claim 22 wherein said linkers are about 25 amino acids in length.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-04-05 2002-10-05 2003-04-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-04-05 2006-10-05 2007-04-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-04-05 2010-10-05 2011-04-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag